Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Alzheimer's Association selects Wiley as its publishing partner

John Wiley and Sons Inc. and the Alzheimer's Association are pleased to announce that the Alzheimer's Association has selected Wiley as its publishing partner for its three publications.

3 Oct 2019

Study: Drops in income may lead to thinking problems, reduced brain health

Young adults who experience annual income drops of 25 percent or more may be more at risk of having thinking problems and reduced brain health in middle age, according to a study published in the October 2, 2019, online issue of Neurology®, the medical journal of the American Academy of Neurology.

3 Oct 2019

Researchers elucidate enzymes that control long-term memory, learning process in the brain

When we first purchase a smart phone, all of our settings and applications are the same. But as time passes, everyone's phones will change drastically as we adapt them to our own individual needs and preferences. In the same way, our memories and life experiences are loaded into our brains, making one person unique from another.

2 Oct 2019

UCI biologists make major breakthrough in combating inflammation linked to Alzheimer's

University of California, Irvine biologists blazing new approaches to studying Alzheimer's have made a major finding on combating inflammation linked to the disease.

1 Oct 2019

Researchers receive $4 million grant to test platform on dementia management

Agitation and aggression, among others, known as behavioral and psychological symptoms, are hallmarks of Alzheimer's disease and related disorders.

1 Oct 2019

Penn researchers win NIA grant to study link between Alzheimer's, dementia, and Parkinson's

The Center for Neurodegenerative Disease Research (CNDR) at the University of Pennsylvania has received a grant expected to total $18.1 million to study the underlying genetic mechanisms that cause Alzheimer's Disease, Dementia, and Parkinson's Disease to progress as well as how those mechanisms are related to each other and to the cell-to-cell spread of these disease proteins.

30 Sep 2019

Lifelong choline supplementation holds potential to prevent Alzheimer's disease

In a new study, Biodesign researchers reveal that a lifelong dietary regimen of choline holds the potential to prevent Alzheimer's disease.

27 Sep 2019

Cellular aging associated with structural changes in the brain

Telomeres are protective caps at the ends of chromosomes that become shorter with each cell division. If they become so short that the genes they protect could be damaged, the cell stops dividing and renewing.

27 Sep 2019

How tau protein causes brain damage in Alzheimer’s disease

Researches have described a new technique to find out how Alzheimer's disease (AD) affects nerve cells.

27 Sep 2019

Non-invasive treatment shows early promise for vestibular migraine attacks

There may be some good news for people with vestibular migraine, a type of migraine that causes vertigo and dizziness with or without headache pain.

26 Sep 2019

UCI researchers receive BRAIN Initiative grant to lead development of new brain mapping tool

Professors Xiangmin Xu and Rozanne Sandri-Goldin, in collaboration with Professors Bert Semler and Todd Holmes at the University of California, Irvine, School of Medicine, were awarded a three-year, $4.3 million Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative grant.

26 Sep 2019

Testing the usability of novel mobile app designed to improve care for Alzheimer's patients

A Regenstrief Institute research scientist is testing a novel mobile app designed to improve care for people with Alzheimer's disease. Daniel Bateman, M.D., has received a career development award from the National Institute on Aging to test the feasibility and usability of the revised Brain CareNotes app.

26 Sep 2019